Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended
Mar. 31, 2024	Mar. 31, 2023
Income Statement [Abstract]
Net product sales	$ 110,403	$ 86,270
Cost of goods sold	13,567	6,942
Gross profit	96,836	79,328
Operating expenses:
Research and development	28,329	41,499
Selling, general, and administrative	88,029	73,957
Changes in fair value of contingent consideration payable	0	251
Restructuring charges	6,045	0
Depreciation and amortization	2,154	1,257
Total operating expenses	124,557	116,964
Loss from operations	(27,721)	(37,636)
Other expense:
Interest income	1,540	2,199
Interest expense	(12,436)	(11,844)
Other expense	(4,966)	(5,938)
Loss before income tax	(43,583)	(53,219)
Income tax (expense) benefit	(4,836)	287
Net loss attributable to common stockholders	$ (48,419)	$ (52,932)
Net loss attributable to common stockholders per common share - basic (in dollars per share)	$ (0.16)	$ (0.18)
Net loss attributable to common stockholders per common share — diluted (in dollars per share)	$ (0.16)	$ (0.18)
Weighted average common shares outstanding - basic (in shares)	302,903,009	291,336,750
Weighted average common shares outstanding - diluted (in shares)	302,903,009	291,336,750

The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.

Name:	us-gaap_CostOfGoodsAndServicesSold
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.